Physician profile
Lisa Vanderpool
NPI 1518349224
$6,089.63
in general payments reported to CMS, 2019-2025
21 companies · $940 in 2025
The $940 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $985 · 2020: $225 · 2021: $679 · 2022: $1,030 · 2023: $968 · 2024: $1,263 · 2025: $940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,945 · Entertainment: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,944.50 |
| Entertainment | $226.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,783.86 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Bausch & Lomb Americas INC. | $984.34 | 2022-2025 | Infuse, Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $745.34 | 2019-2021 | |
| Coopervision INC. | $394.62 | 2019-2025 | Myday Contact Lens, Biofinity Contact Lens |
| Optos, INC. | $362.35 | 2022-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Sun Pharmaceutical Industries INC. | $267.65 | 2020-2025 | |
| Maculogix, INC. | $196.06 | 2019-2021 | |
| Lombart Brothers, INC. | $186.79 | 2025 | Opd-III |
| Allergan, INC. | $173.72 | 2022 | |
| Lkc Technologies, INC. | $165.25 | 2024-2025 | |
| Johnson & Johnson Vision Care, INC. | $156.70 | 2019-2022 | |
| Sight Sciences, INC. | $146.68 | 2023 | Tearcare System |
| Horizon Therapeutics Plc | $121.95 | 2022 | |
| Lumenis, INC | $119.74 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $105.53 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $58.10 | 2023-2024 | Tyrvaya |
| Biotissue Holdings INC. | $45.40 | 2020-2022 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.93 | 2023 | |
| Oasis Medical, INC. | $12.92 | 2020 | |
| Abb Con-Cise Optical Group LLC | $9.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Vanderpool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.